Electrolysis: processes – compositions used therein – and methods – Electrolytic analysis or testing – Of biological material
Reexamination Certificate
2000-12-13
2003-09-16
Tung, T. (Department: 1753)
Electrolysis: processes, compositions used therein, and methods
Electrolytic analysis or testing
Of biological material
C205S775000, C436S069000
Reexamination Certificate
active
06620310
ABSTRACT:
FIELD OF THE INVENTION
The field of this invention is coagulation, and particularly coagulation testing.
BACKGROUND
Coagulation is defined as a transformation of a liquid or sol into a soft, semi-solid or solid mass. Blood naturally coagulates to form a barrier when trauma or pathologic conditions cause vessel damage. There are two well-recognized coagulation pathways: the extrinsic or thromboplastin-controlled and the intrinsic or prothrombin/fibrinogen-controlled coagulation pathway. Both the extrinsic and intrinsic pathways result in the production of thrombin, a proteolytic enzyme which catalyzes the conversion of fibrinogen to fibrin.
Coagulation tests which measure a blood sample's ability to form a clot or coagulate have been developed and used to measure the Prothrombin Time (PT) of a blood sample. Such tests are commonly referred to as PT tests. PT tests find use in a number of different applications. For example, PT tests find use in monitoring patients undergoing anticoagulant therapy. Other situations where PT tests find use include tests to determine: acquired platelet function defect; congenital platelet function defects; congenital protein C or S deficiency; deep intracerebral hemorrhage; DIC (Disseminated intravascular coagulation); factor II deficiency; factor V deficiency; factor VII deficiency; factor X deficiency; hemolytic-uremic syndrome (HUS); hemophilia A; hemophilia B; hemorrhagic stroke; hepatic encephalopathy; hepatorenal syndrome; hypertensive intracerebral hemorrhage; idiopathic thrombocytopenic purpura (ITP); intracerebral hemorrhage; lobar intracerebral hemorrhage; placenta abruption; transient ischemic attack (TIA); Wilson's disease; and the like. As such, PT tests find use in a variety of different applications.
A number of different PT determination tests and devices have been developed. Such devices and test protocols include both optical based devices, such as those described in U.S. Pat. No. 6,084,660; to R. Shartle; and electrochemical based devices, such as those described in U.S. Pat. Nos. 6,046,051; 6,060,323 and 6,066,504; all to A. Jina. In this latter group of patents a device is disclosed which is suitable for electrochemical determination of a change of fluid viscosity in a sample, where the device is characterized by the presence of side-by-side electrodes. This configuration requires the use of relatively large volumes of sample and a measurement protocol that implements a time dependent deconvolution of the background response; i.e., signal is measured over time and is then distinguished over background. Thus, the protocols employed with Jina's devices are more complicated and perhaps less robust than the protocols used in the present invention described below.
While a number of different PT determination tests and devices have been developed, there continues to be a need for additional protocols and devices. Of particular interest would be the development of PT system that provided for rapid and accurate PT determinations with small sample volumes using inexpensive device components, such as disposable reagent strips. Of even greater interest would be the development of an electrochemical device and protocol which exhibits the above desirable parameters, is suitable for use with small sample volumes and can provide a simple-to-interpret signal that converges to a steady-state value.
RELEVANT LITERATURE
United States Patent of interest include: U.S. Pat. Nos. 6,084,660; 6,066,504; 6,060,323, 6,046,051; 5,942,102; 5,916,522; 5,628,961; 5,554,531; and 5,300,779. Also of interest are WO 97/18465; WO 95/06868; EP 974840 and GB 1 299 363.
SUMMARY OF THE INVENTION
Methods and devices for electrochemically detecting a change in the viscosity of a fluid are provided. In the subject methods, a fluid sample is introduced into an electrochemical cell having oppositely spaced apart working and reference electrodes. An electric potential is applied to the cell to first achieve a steady state cell current. A decrease in the steady state cell current is then detected and related to a change in viscosity of the sample. In many embodiments, the sample is blood and the change in viscosity is related to the onset of coagulation in the blood sample, and often the PT of the blood sample. Also provided are test strips, kits thereof and meters for use in practicing the subject methods.
REFERENCES:
patent: 5300779 (1994-04-01), Hillman et al.
patent: 5437999 (1995-08-01), Diebold et al.
patent: 5554531 (1996-09-01), Zweig
patent: 5628961 (1997-05-01), Davis et al.
patent: 5725747 (1998-03-01), Pinkowski et al.
patent: 5916522 (1999-06-01), Boyd et al.
patent: 5942102 (1999-08-01), Hodges et al.
patent: 6046051 (2000-04-01), Jina
patent: 6060323 (2000-05-01), Jina
patent: 6066504 (2000-05-01), Jina
patent: 6084660 (2000-07-01), Shartle
patent: 6352630 (2002-03-01), Frenkel et al.
patent: 0 974 840 (2000-01-01), None
patent: 1 299 363 (1972-12-01), None
patent: WO 95/06868 (1995-03-01), None
patent: WO 97/18465 (1997-05-01), None
patent: 9947907 (1999-09-01), None
Ohara Timothy J.
Shartle Robert Justice
Teodorczyk Maria
Becking Frank P.
Bozicevic Field & Francis LLP
Lifescan Inc.
Noguerola Alex
Tung T.
LandOfFree
Electrochemical coagulation assay and device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Electrochemical coagulation assay and device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Electrochemical coagulation assay and device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3056085